Although we could not identify the underlying mechanism or the link among resistin, leptin, and CD163/CD68 expression levels, our data suggest that serum resistin levels and leptin levels have specific roles in the regulation of ATM in patients with modest obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.